Since the original SARS-CoV-2 virus emerged from Wuhan, China, in late December 2019, a number of variants have arisen with enhanced infectivity, and some may even be capable of escaping the existing vaccines. Here we describe a rapid automated nucleic acid microarray hybridization and readout in less than 15 min using the Fraunhofer lab-on-a-chip platform for identification of bacterial species and antibiotic resistance. This platform allows a fast adaptation of new biomarkers enabling identification of different genes and gene mutations, such as those seen in the case the SARS-CoV-2 variants.
Keywords: Biomarker; COVID-19; LOC; Lab-on-a-chip; Microarray; SARS-CoV-2; Variant.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.